Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-08-05

Clinical Trial Update: Arabin Pessary Combine With Vaginal Progesterone Compare With Vaginal Progesterone Alone to Prevent Preterm Delivery in Singleton Pregnancies [Phase 3]

View source ↗

Summary

Phase 3 trial comparing Arabin pessary plus vaginal progesterone versus vaginal progesterone alone for preventing preterm delivery in singleton pregnancies; stu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Illinois at Chicago | Conditions: Focus: Prevent Preterm Delivery, Incidental Short Cervix at Mid-trimester | Phase 3 | Status: TERMINATED